President Trump's 2025 World Trade Week proclamation reaffirms a commitment to balanced and reciprocal trade that prioritizes American workers and industries.

It highlights the administration's actions, including tariffs and job training initiatives, to combat unfair trade practices and bring jobs back to the US. The proclamation declares May 18-24, 2025, as World Trade Week, celebrating the achievements of American trade, signaling a continued focus on an 'America First' trade policy.

President Trump's executive order prioritizes the revitalization of the American nuclear energy industry.

The order mandates multiple actions by federal agencies, including developing a national policy for spent nuclear fuel management, expanding domestic uranium production and enrichment, utilizing the Defense Production Act to secure voluntary agreements with domestic nuclear energy companies, and funding the expansion of nuclear energy related workforce development.

The overarching goal is to achieve energy independence, strengthen national security, and establish American energy dominance.

President Donald J. Trump's May 22, 2025 proclamation designates May 22nd as National Maritime Day, commemorating the S.S. Savannah's transatlantic voyage and honoring the United States Merchant Marine. The proclamation emphasizes the crucial role of merchant mariners in national defense, having supported military operations throughout history, and their importance to the American economy through global trade.

President Trump also highlights the recent Executive Order focused on restoring American maritime dominance through investment in shipbuilding, regulatory reform, and expanded training.

The proclamation concludes with a call for Americans to observe the day and display the national flag.

President Trump issued an order modifying reciprocal tariff rates on goods imported from China.

This action, following preceding executive orders imposing tariffs, reflects ongoing discussions with the PRC aimed at addressing trade imbalances and national security concerns.

The order suspends certain tariffs for 90 days, while imposing a 10% ad valorem rate on other goods.

Simultaneously, it makes adjustments to other tariff rates, aiming to improve trade reciprocity.

President Donald J. Trump issued an executive order to address the high cost of prescription drugs in the United States.

The order mandates that the government secure the lowest prices paid by other developed nations for pharmaceuticals.

To achieve this, it instructs various federal agencies—including the Secretaries of Commerce and Health and Human Services—to utilize a multi-pronged approach involving negotiations, potential rulemaking, and legal action against anti-competitive practices.

Failure by pharmaceutical companies to comply with the new pricing goals could trigger stricter regulatory measures, including direct-to-consumer sales facilitation at the most-favored-nation price and the possible certification to Congress for importation of lower-cost drugs from other developed countries.

The order also addresses potential legal and budgetary challenges related to its implementation.

This executive order aims to curb overcriminalization in federal regulations.

It addresses concerns about the excessive number and complexity of regulations, many carrying potential criminal penalties, by requiring agencies to review and report on existing criminal regulatory offenses, clarifying mens rea requirements in future rulemaking, and establishing guidelines for agency referrals to the Department of Justice for potential criminal prosecution.

Exemptions exist for immigration laws and national security matters.

President Trump issued an executive order aiming to bolster domestic pharmaceutical production by streamlining relevant regulations.

The order directs the FDA, EPA, and the Army Corps of Engineers to review and reduce bureaucratic hurdles for new and expanding pharmaceutical manufacturing facilities.

This also includes measures to improve the inspection of foreign pharmaceutical manufacturing facilities and coordinate environmental permits.

The goal is to increase both the speed and domestic capacity of pharmaceutical product creation, enhance national security, and improve medicine affordability.

President Donald J. Trump's proclamation declares May 4-10, 2025, as National Small Business Week.

The proclamation emphasizes the vital contribution of small businesses to the U.S. economy, job creation, and innovation.

While acknowledging recent challenges faced by small businesses, it highlights the administration's efforts to address issues like unfair trade practices and burdensome regulations through initiatives such as the Made in America Manufacturing Initiative. The proclamation serves as a recognition of small business owners and entrepreneurs.